In this work, we provide the first in vivo evidence supporting the role of a member of the highly conserved T2 ribonuclease gene family in tumor suppression by means of the functional involvement of molecular and/or cellular effectors belonging to both the innate and adaptive immune systems. The gene discussed is RNASET2; the disease is neoplasm.